BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35566407)

  • 21. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
    Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of human B cell precursor-leukemia cell lines.
    Matsuo Y; Drexler HG
    Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients.
    Gupta DG; Varma N; Naseem S; Sachdeva MUS; Bose P; Binota J; Kumar A; Gupta M; Rana P; Sonam P; Malhotra P; Trehan A; Khadwal A; Varma S
    Turk J Haematol; 2022 Feb; 39(1):1-12. PubMed ID: 34617433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
    Uckun FM; Song CW
    Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection.
    Thulasi Raman R; Anurekha M; Lakshman V; Balasubramaniam R; Ramya U; Revathi R
    Leuk Lymphoma; 2020 Aug; 61(8):1974-1980. PubMed ID: 32281503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia.
    van Delft FW; Bellotti T; Luo Z; Jones LK; Patel N; Yiannikouris O; Hill AS; Hubank M; Kempski H; Fletcher D; Chaplin T; Foot N; Young BD; Hann IM; Gammerman A; Saha V
    Br J Haematol; 2005 Jul; 130(1):26-35. PubMed ID: 15982341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
    Nakamura A; Tsurusawa M; Kato A; Taga T; Hatae Y; Miyake M; Mimaya J; Onodera N; Watanabe A; Watanabe T; Kanegane H; Matsushita T; Iwai A; Hyakuna N; Gushi K; Kawakami T; Sekine I; Izichi O; Asami K; Kikuta A; Tanaka A; Fujimoto T;
    Leuk Lymphoma; 2001 Jul; 42(3):393-8. PubMed ID: 11699404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
    Amare Kadam PS; Raje GC; Pais AP; Banavali S
    Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
    Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
    Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of CD34/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children.
    Zeidan MA; Kamal HM; El Shabrawy DA; Esh AM; Sattar RH
    Blood Cells Mol Dis; 2016 Jul; 59():113-8. PubMed ID: 27282579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.
    Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC
    Am J Clin Pathol; 2004 Apr; 121(4):512-25. PubMed ID: 15080303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
    Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.
    Schwartz S; Rieder H; Schläger B; Burmeister T; Fischer L; Thiel E
    Leukemia; 2003 Aug; 17(8):1589-95. PubMed ID: 12886247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
    Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.